Schonfeld Strategic Advisors LLC Oncocyte Corp Transaction History

Schonfeld Strategic Advisors LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.2 - $0.35 $360 - $630	-1,800 Reduced 8.37%	19,700 $4,000
Q1 2023 May 15, 2023	SELL	$0.2 - $0.49 $80,480 - $197,176	-402,400 Reduced 94.93%	21,500 $7,000
Q4 2022 Feb 14, 2023	SELL	$0.25 - $15.6 $81,450 - $5.08 Million	-325,800 Reduced 43.46%	423,900 $135,000
Q3 2022 Nov 14, 2022	SELL	$0.76 - $15.98 $157,852 - $3.32 Million	-207,700 Reduced 21.69%	749,700 $547,000
Q2 2022 Aug 15, 2022	SELL	$0.86 - $1.53 $45,838 - $81,549	-53,300 Reduced 5.27%	957,400 $862,000
Q1 2022 May 16, 2022	SELL	$1.15 - $2.25 $23,919 - $46,800	-20,800 Reduced 2.02%	1,010,700 $1.51 Million
Q4 2021 Feb 14, 2022	SELL	$2.04 - $3.59 $488,512 - $859,686	-239,467 Reduced 18.84%	1,031,500 $2.24 Million
Q3 2021 Nov 16, 2021	SELL	$3.53 - $5.89 $416,677 - $695,249	-118,039 Reduced 8.5%	1,270,967 $4.52 Million
Q2 2021 Aug 16, 2021	SELL	$3.77 - $6.0 $881,493 - $1.4 Million	-233,818 Reduced 14.41%	1,389,006 $7.97 Million
Q1 2021 May 17, 2021	BUY	$2.39 - $6.5 $3.57 Million - $9.72 Million	1,495,424 Added 1173.8%	1,622,824 $8.42 Million
Q4 2020 Feb 16, 2021	BUY	$1.38 - $2.63 $175,812 - $335,062	127,400 New	127,400 $304,000
Q3 2019 Nov 14, 2019	SELL	$1.59 - $2.51 $302,895 - $478,154	-190,500 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$2.49 - $5.45 $1.69 Million - $3.7 Million	-678,293 Reduced 78.07%	190,500 $474,000
Q1 2019 May 15, 2019	BUY	$1.47 - $5.91 $1.28 Million - $5.13 Million	868,793 New	868,793 $3.43 Million

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $266M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.